Enhanced cytotoxic response of natural killer cells to lnterleukin-2 in alzheimer’s disease

Dementia and Geriatric Cognitive Disorders

Volumn 7, Issue 6, 1996, Pages 343-348

  Solerte, Sebastiano Bruno ^a   Fioravanti, Marisa ^a   Severgnini, Silvia ^a   Locatelli, Mattia ^a   Renzullo, Maria ^a   Pezza, Nunziata ^a   Cerutti, Nadia ^a   Ferrari, Ettore ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Alzheimer s disease; Dementia; Enhanced cytotoxic response of natural killer cells to lnterleukin 2 in alzheimer s disease; Lnterleukin 2; Natural killer cell

Indexed keywords

INTERLEUKIN 2;

AGED; ALZHEIMER DISEASE; ARTICLE; CELL ACTIVITY; CELL MEDIATED CYTOTOXICITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; HUMAN; MALE; MULTIINFARCT DEMENTIA; NATURAL KILLER CELL; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; CELL DEATH; DEMENTIA, MULTI-INFARCT; FEMALE; HUMANS; INTERLEUKIN-2; KILLER CELLS, NATURAL; MALE; NEUROPSYCHOLOGICAL TESTS; OSMOLAR CONCENTRATION; RECOMBINANT PROTEINS; REFERENCE VALUES;

EID: 0029822515     PISSN: 14208008     EISSN: 14219824     Source Type: Journal    
DOI: 10.1159/000106901     Document Type: Article

References (51)

1. Ishii T, Haga S: Identification of components of immunoglobulins in senile plaques by means of fluorescent technique. Acta Neuropathol 1975:32:157-162.
2. Miller AE, Neighbour PA, Katzman R, Aronson M, Lipkowitz R: Immunological studies in senile dementia of the Alzheimer type: Evidence for enhanced suppressor cell activity. Ann Neurol 1981;10:506-510.
3. Rogers J, Lubcr-Narod J, Styren SD, Civin VVH: Expression of immune system-associated antigens by cells of the human central nervous system: Relationship to the pathology of Alzheimer's disease. Ncurobiol Aging 1988;9:339-349.
4. Gautrin D. Gauthier S: Alzheimer's disease: Environmental factors and etiologic hypothesis. Can J Neurol Sci 1989:16:375-387.
5. Ikeda T, Yamamoto K, Takahashi K, Kancyu-ki H. Yamada M: lntcrlcukin-2 receptor in peripheral blood lymphocytes of Alzheimer's disease patients. Acta Psychiatr Scand 1991: 84:262-265.
6. Hubcrman M, Shalit F, Roth-Dcri I, Gutman G, Brodie C, Kott E, Sredini B: Correlation of cytokine secret ion by mononuclear cells of Alzheimer patients and their disease stage. J Ncu-roimmunol 1994:52:147-152.
7. McGeer PL, Rogers J, McGccr EG: Neuroim-munc mechanisms in Alzheimer disease pathogenesis. Alzheimer Dis Assoc Disord 1994:8: 149-158.
8. Freckcr MF, Pryse-Phillips WE, Strong HR: Immunological associations in familial and non-familial Alzheimer patients and their families. Can J Neurol Sci 1994:21:112-119.
9. Albright JW, Albright JF: Age-associated decline in natural killer (NK) activity reflects primarily a defect in function of NK cells. Mcch Ageing Dev 1985;31:295-306.
10. Mysliwska J. Mysliwski A. Witkowski J: Age-dependent decline of natural killer and antibody-dependent cell mediated cytotoxicity of human lymphocytes is connected with decrease of their acid phosphatase activity. Mcch Ageing Dev 1985;31:1-11.
11. Bender BS, Chresl FJ, Adler WH: Phenotypic expression of natural killer cell association membrane antigens and cytolytic function of peripheral blood cells from different aged humans. J Clin Lab Immunol 1986:21:31-36.
12. Krishnaray R. Blandford G: Age-associated alterations in human natural killer cells. I. Increased activity as pcrconvcntional and kinetic analysis. Cell Immunol Immunopathol 1987: 45:268-285.
13. Krishnaray R, Blandford G: Age-associated alterations in human natural killer cells. 2. Increased frequency of selective NK subsets. Cell Immunol Immunopathol 1988:114:137- 145.
14. Araga S, Kagimoto H, Funamoko K, Takahashi K: Reduced natural killer cell activity in patients with dementia of the Alzheimer type. Acta Neurol Scand 1991:84:259-263.
15. Shar H, Golub SH: Signals for activation of natural killer and natural-killer like activity. Nat Immun Cell Growth Rcgul 1985:4:113-119.
16. Chan WC, Masih LB, Nicholson J, Voglcr WR, Yu G, Nasr S: Large granular lymphocyte proliferation with the natural killer cell phenotype. Am J Clin Pathol 1992:97:353-358.
17. Lotzova E. Ades EW: Natural killer cells: Definition, heterogeneity, lytic mechanism, function and clinical application. Nat Immun Cell Growth Regul 1989;8:1-9.
18. Trinchicri G: Biology of natural killer cells. Adv Immunol 1959.47:187-376.
19. Gidlund M. Om A. Wigzell H. Senik A. Grosser I: Enhanced NK cell activity in mice injected with interferon and interferon inducers. Nature 1978:273:759-761.
20. Hcnncy CS. Kuribayashi K. Kern DE. Gillis S: Interleukin-2 augments natural killer cells activity. Nature 1981:291:335-337.
21. Trinchieri G. Santoli D: Enhancement of human natural killer cell activity by interferon. J Immunol 1978:120:1845-1850.
22. Ligthart GJ. Corberand JX. Fourmicr C. Gala-naud P, Hijmans W, Kenncs B. Muller-Herme-link HK. Steinmann GG: Admission criteria for immunogerontological studies in man: The SENIEUR protocol. Mcch Ageing Dev 1984: 28:47-55.
23. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 3, revised. Washington. American Psychiatric Association. 1987.
24. McKliann G, Drachman D. Folstein M, Katzman R. Price D. Stadlan EM: Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA Workgroup under the aus-picesofDcpartment of Health and Human Services Task Force on Alzheimer’s disease. Neurology 1984;34:939-944.
25. Hachinski VC, Lassen NA, Marshall J: Multiinfarct dementia: A cause of mental deterioration in the elderly. Lancet 1974:2:207-210.
26. Weintraub S. Baratz R. Mcsulam MM: Daily living activities in the assessment of dementia: in Corkin S. Davis KL. Crowdcn JH. Usdin E. Wurtmann JJ (eds): Alzheimer's Disease: A Report of Progress in Research. New York. Raven Press. 1982. pp 109-192.
27. Folstein M, Folstein S, McHugh PR: Mini Mental Slate: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975:12:189-198.
28. Timonen T. Ranki A. Saksele E. I layry P: Fractionation. morphological and functional characterization of effector cells responsible for human natural killer activity against cell-line targets. Cell Immunol 1979:48:133-139.
29. Boyum A: Isolation of mononuclear cells and granulocytes from human blood. Scand Clin Lab Invest l968:21(suppl):3l-50.
30. Galti G. Cavallo R. Sartori ML. Del Ponte D. Maseru R. Salvadori A. Carignola R. Angeli A: Inhibition by cortisol of human natural killer (NK) cell activity. J Steroid Biochcm 1987:26: 49-58.
31. Hollbrock NJ, Cox WI, Horner HC: Direct suppression of natural killer activity in human peripheral blood leukocyte cultures by glucocorticoids and its modulation by interferon. Cancer Res 1983:43:4019-4025.
32. Korzeniewski C. Callcwaert DM: An enzyme-release assay for natural cytotoxicity. J Immunol Methods 1983:64:313-320.
33. Pross IIF, Baynes MG, Rubin P, Shragge P, Patterson MS: Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantification of natural killer cell activity. J Clin Immunol 1981:1:51-63.
34. McRae A. Dahlstrom A: Immune responses in brains of Alzheimer's and Parkinson's disease patients: Hypothesis and reality. Rev Neurosci 1992:3:79-97.
35. Ikeda T. Yamamoto K. Takahashi K. Yamada M: Immune system-associated antigens on the surface of peripheral blood lymphocytes in patients with Alzheimer’s disease. Acta Psychiatr Scand 1991:83:444-448.
36. Wckerle H. Linington C. Lassmann H. Meyer-mann R: Cellular immune reactivity within the CNS. Trends Neurosci 1986:9:271-277.
37. Hanisch U, Scto D, Quirion R: Modulation of hippocampal acetylcholine release: A potent central action of interleukin-2. J Neurosci 1939;13:3368-3374.
38. Bindoni M, Perciavalle V, Berretta S, Belluar-do N. Diamastcin T: Interleukin 2 modifies the bioelectric activity of some neurosecretory nuclei in the rat hypothalamus. Brain Res 1988; 462:10-14.
39. Tancredi V, Zona C. Velotti F, Eusebi F. Santoni A: Interleukin-2 suppresses established long-term potentiation and inhibits its induction in the rat hippocampus. Brain Res 1990; 525:149-151.
40. Denikoff KD. Rubinow DR. Papa MZ. Simpson C. Seipp CA. Lotzc MT. Chang AE, Rosen-stein D, Rosenberg DA: The neuropsychiatrie effectsof treatment with interleukin-2 and lym-phokine activated killer cells. Ann Intent Med 1987;107:293-300.
41. Araujo DM. Lapchak PA. Collier B. Quirion R: Localization of interleukin-2 receptors in the rat brain: Interaction with the cholinergic system. Brain Res 1989;498:257-266.
42. Ligthart GJ, Schmit HR, Himans W: Natural killer cell function is not diminished in the healthy aged and is proportional to the number of NK cells in the peripheral blood. Immunology 1989;68:396-402.
43. Thompson JS. Wekstcin DR, Rhoades JL. Kirkpatrick C. Brown SA. Roszntan T, Straus R, Tictz N: The immune status of healthy centenarians. J Am GerialrSoc 1984;2:274-281.
44. Murasko DM, Nelson BJ, Silver R, Matour D. Kaye D: Immunological response in an elderly population with a mean age of 85. Am J Med 1986;81:612-618.
45. McGeer PL, McGeer EG, Kawamake T, Ya-mada T, Akiyanta H: Reactions of the immune system in chronic degenerative neurological diseases. Can J Neurol Sci 1991;18:376-379.
46. Itagaki S. McGeer PL. Akiyama H: Presence of T-cytotoxic suppressor and leucocyte common antigen positive cells in Alzheimer’s disease brain tissue. Ncurosci Lett 1988;91:259-264.
47. Rogers J, Luber-Narod J, Styren CD, Civin WH: Expression of immune system associated antigens by cells of the human central nervous system: Relationship to the pathology of Alzheimer's disease. Neurobiol Aging 1988:9:339-349.
48. Dickson DW, Lee SC, Mattiacc LA. Yen SH. Brosman C: Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 1993;7:75-83.
49. Loughlin AJ, Woodragc MN, Cuzner ML: Regulation of Fc receptor and major histocompatibility antigen expression on isolated rat microglia by tumor necrosis factor, interleukin-1 and lipopolysaccharide: Effects on interferon-y induced activation. Immunology 1992;75:170-175.
50. Sei Y, Vitkovic L, Yokoyama MM: Cytokines in the central nervous system: Regulatury roles in neuronal function, cell death and repair. Neuroimmunomodulation 1995;2:121-123.
51. Solcrtc SB, Fioravanti M, Scvcrgnini S, Loca-tclli M, Govoni S, Ferrari F.: Effects of 1-intcr-feron on increased natural killer cell activity in Alzheimer’s disease. Submitted.